Transparency Market Research Reports included a detailed market survey and analysis trends on “Cancer/Tumor Profiling Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure.Cancer is a fatal disease characterized by uncontrolled
cell division. It is primarily caused by environmental factors that
mutate the gene encoding for cell regulation. The resultant cell
aberration leads to abnormal cell growth that destroys the surrounding
normal tissue and thus spreads the disease to vital organs.
Browse Full Report with TOC: http://www.transparencymarketresearch.com/cancer-tumor-profiling.html
Cancer
diagnosis is performed in a number of ways that include screening tests
and medical imaging. According to WHO, cancer is one of the leading
cause of death and is estimated to account for 11.5 million deaths in
2030 worldwide. Cancer diagnosis is performed in a number of ways that
include screening tests and medical imaging. Nowadays, profiling of
tumor is done to gain knowledge about patient’s cancer profile and
genomic alterations that help physicians to guide a patient with most
appropriate therapy. Additionally, profiling also helps physicians to
remove therapies which are unlikely to be successful and thus reduces
the errors and trial process.
The
global cancer profiling market is expected to witness massive growth in
near future due to huge funds and investments and technological
advancements. Additionally, paradigm shift towards point of care
diagnostics, growing demand for personalized medicines and cost
effective treatment modalities are some of the major reasons expected to
increase the market share of cancer profiling in near future. Moreover,
personalized medicines have been a promising approach in early
diagnosis, disease prognosis and research applications. Increasing
demand for targeted therapy and rising cases of cancer are also expected
to fuel the market growth.
Global
cancer/tumor profiling market can be categorized on the basis of
technology, application and segment. The technology segment can be
further categorized into next-generation sequencing,
immunohistochemistry, quantitative PCR, microarray and
fluroscence/chromogenic in-situ hybridization. Application segment of
the tumor profiling market can be subdivided further into personalized
medicines, diagnostics, biomarker discovery, prognosis and research
purpose. Furthermore, the market can also be divided on the basis of
different segments such as genomics, proteomics, epigenetics and
metabolomics market. Of these above mentioned application segments
personalized medicines is expected to witness the highest growth rate in
near future owing to its ability treat cancer conditions effectively
and reduce healthcare expenditure.
Geographically,
North America accounts for the largest share of the global cancer
profiling market followed by the European region. Rising incidences of
patients suffering from cancer each year and favorable government
measures that are focused towards proper screening and diagnosing are
some of the factors held responsible for leadership position of these
region. Additionally, presence of large number of technology providers
and availability of better research and development facilities are
expected to trigger the growth of cancer profiling market in North
America and European markets. However, in the near future Asian region
and Latin American region is expected to show healthy growth in the near
future due to increased purchasing power of patients, economic
developments and rising incidence of cancer. Moreover, rising demand for
safe and cost effective diagnostics and therapeutics is another major
driver of this market.
Some of the
major players operating in cancer profiling market include Boreal
Genomics, Inc., Genomic Health, Inc., Caris Life Sciences, Life
Technologies Corporation, Illumina, Inc., Oxford Gene Technology Ltd.,
Neogenomics Laboratories, Precision Therapeutics, Inc. Nanostring
Technologies, Ribomed Biotechnologies, Precision Therapeutics, Inc.,
Oncopath Laboratory and others.
This research report analyzes this market depending
on its market segments, major geographies, and current market trends.
Geographies analyzed under this research report include
- North
America
- Asia
Pacific
- Europe
- Rest
of the World
This report provides comprehensive
analysis of
- Market
growth drivers
- Factors
limiting market growth
- Current
market trends
- Market
structure
- Market
projections for upcoming years
More Reports on Medical Devices Market:
Transparency
Market Research (TMR) is a market intelligence company providing global
business research reports and consulting services. Our exclusive blend
of quantitative forecasting and trends analysis provides forward-looking
insights for thousands of decision-makers.
0 comments:
Post a Comment